Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
Public ClinicalTrials.gov record NCT01450761. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized, Multicenter, Double-Blind, Phase 3 Trial Comparing the Efficacy of Ipilimumab Plus Etoposide/Platinum Versus Etoposide/Platinum in Subjects With Newly Diagnosed Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC)
Study identification
- NCT ID
- NCT01450761
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 1,351 participants
Conditions and interventions
Conditions
Interventions
- Carboplatin Drug
- Cisplatin Drug
- Etoposide Drug
- Ipilimumab Biological
- Placebo matching Ipilimumab Biological
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 12, 2011
- Primary completion
- Mar 18, 2015
- Completion
- May 16, 2017
- Last update posted
- Jul 7, 2020
2011 – 2017
United States locations
- U.S. sites
- 42
- U.S. states
- 22
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Genesis Cancer Center | Hot Springs | Arkansas | 71913 | — |
| Sutter Medical Center | Auburn | California | 95602 | — |
| UCSD Moores Cancer Center | La Jolla | California | 92093 | — |
| University Of Colorado Cancer Center | Aurora | Colorado | 80045 | — |
| Florida Cancer Specialists S. | Fort Myers | Florida | 33916 | — |
| Cancer Specialists, LLC | Jacksonville | Florida | 32256 | — |
| Lake City Cancer Care | Lake City | Florida | 32024 | — |
| Florida Cancer Specialists | St. Petersburg | Florida | 33705 | — |
| Medical Oncology, LLC | Augusta | Georgia | 30901 | — |
| Quincy Medical Group | Quincy | Illinois | 62301 | — |
| Presence Medical Group Hematology Oncology | Skokie | Illinois | 60077 | — |
| SIU School Of Medicine | Springfield | Illinois | 62794-9678 | — |
| St. Francis Medical Group Oncology And Hematology Specialist | Indianapolis | Indiana | 46237 | — |
| Cancer Center Of Kansas | Wichita | Kansas | 67214 | — |
| Ashland Bellefonte Cancer Center | Ashland | Kentucky | 41101 | — |
| University Of Kentucky | Lexington | Kentucky | 40536-0093 | — |
| Montgomery Cancer Center | Mount Sterling | Kentucky | 40353 | — |
| St Joseph Mercy Hospital | Ypsilanti | Michigan | 48197 | — |
| St. Luke'S Cancer Institute | Kansas City | Missouri | 64111 | — |
| Southeast Nebraska Hematology & Oncology Consultants, P.C. | Lincoln | Nebraska | 68510 | — |
| Regional Cancer Care Associates, LLC/Cherry Hill Division | Cherry Hill | New Jersey | 08003 | — |
| Memorial Sloan Kettering Nassau | New York | New York | 10065 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| Oncology Hematology Care, Incorporated | Cincinnati | Ohio | 45242 | — |
| University Hospitals | Cleveland | Ohio | 44106 | — |
| Signal Point Clinical Research Center, Llc | Middletown | Ohio | 45042 | — |
| Oklahoma Cancer Specialists and Research Institute, LLC | Tulsa | Oklahoma | 74104 | — |
| Providence Portland Medical Center | Portland | Oregon | 97213 | — |
| Kaiser Permanente | Portland | Oregon | 97227 | — |
| Chattanooga Oncology Hematology Associates | Chattanooga | Tennessee | 37404 | — |
| Associated in Oncology and Hematology | Chattanooga | Tennessee | 37421 | — |
| The Jones Clinic, PC | Germantown | Tennessee | 38138 | — |
| Tennessee Cancer Specialists | Knoxville | Tennessee | 37909 | — |
| Thompson Cancer Survival Center | Knoxville | Tennessee | 37916 | — |
| Tennessee Oncology, PLLC | Nashville | Tennessee | 37203 | — |
| Henry-Joyce Cancer Center | Nashville | Tennessee | 37232 | — |
| University Of Texas, M. D. Anderson Cancer Center | Houston | Texas | 77030 | — |
| Joe Arrington Cancer Research And Treatment Center | Lubbock | Texas | 79410 | — |
| Huntsman Cancer Hospital | Salt Lake City | Utah | 84112 | — |
| Virginia Cancer Institute | Richmond | Virginia | 23230 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Mary Babb Randolph Cancer Center | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 183 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01450761, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 7, 2020 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01450761 live on ClinicalTrials.gov.